GA: gestational age; gw: gestational week *: number of samples analysed for anti-D concentration per woman
Legends
Figure 1. Anti-D concentration (IU/L) at inclusion in the study at week 38±1, n=39, after administration of RAADP 1500 IU in gestational week 28. The dotted line represents LOD for detection of Anti-D with type-and-screen, 10 IU/L (2 µg/L), with 17/39 below LOD.
Figure 2. Increase of anti-D IgG after administration of RAADP 1500 IU in pregnancy week 38 was quantified by flow cytometry one week after administration. Linear regression analysis showed a significant correlation to body mass index, p=0.0118, n=39.
Figure 3.
Concentrations of anti-D measured by flow cytometry at different time points after delivery. Data are shown as box plots with median values and quartiles in the box and the range as whiskers. n = no of anti-D analyses performed at delivery and each week after delivery.